Lantheus Holdings Inc.

60.80+0.1400+0.23%Vol 817.34K1Y Perf 132.24%
Feb 3rd, 2023 16:00 DELAYED
BID58.89 ASK62.68
Open59.82 Previous Close60.66
Pre-Market- After-Market60.80
 - -  - -%
Target Price
100.40 
Analyst Rating
Strong Buy 1.00
Potential %
65.13 
Finscreener Ranking
★★★★+     54.98
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     50.67
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     72.29
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
56.97 
Earnings Rating
Strong Buy
Market Cap4.18B 
Earnings Date
23rd Feb 2023
Alpha0.03 Standard Deviation0.17
Beta0.75 

Today's Price Range

59.7660.93

52W Range

25.4987.47

5 Year PE Ratio Range

-56.6029.40

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
8.19%
1 Month
19.17%
3 Months
0.33%
6 Months
-14.65%
1 Year
132.24%
3 Years
247.03%
5 Years
177.63%
10 Years
-

TickerPriceChg.Chg.%
LNTH60.800.14000.23
AAPL154.503.68002.44
GOOG105.22-3.5800-3.29
MSFT258.35-6.2550-2.36
XOM111.920.77000.69
WFC47.580.35000.74
JNJ164.61-0.9300-0.56
FB196.640.99000.51
GE81.96-1.9800-2.36
JPM141.092.15001.55
 
ProfitabilityValueIndustryS&P 500US Markets
59.00
21.00
27.00
-0.10
21.92
RevenueValueIndustryS&P 500US Markets
671.90M
9.76
9.03
6.28
Earnings HistoryEstimateReportedSurprise %
Q03 20220.750.9020.00
Q02 20220.640.8126.56
Q01 20220.410.97136.59
Q04 20210.170.2547.06
Q03 20210.060.0833.33
Q02 20210.050.11120.00
Q01 2021-0.010.05600.00
Q04 20200.030.07133.33
Earnings Per EndEstimateRevision %Trend
12/2022 QR0.878.75Positive
12/2022 FY3.526.99Positive
3/2023 QR0.959.20Positive
12/2023 FY3.883.47Positive
Next Report Date23rd Feb 2023
Estimated EPS Next Report0.87
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume817.34K
Shares Outstanding68.83K
Shares Float57.11M
Trades Count13.84K
Dollar Volume49.24M
Avg. Volume939.91K
Avg. Weekly Volume797.00K
Avg. Monthly Volume898.94K
Avg. Quarterly Volume1.12M

Lantheus Holdings Inc. (NASDAQ: LNTH) stock closed at 60.8 per share at the end of the most recent trading day (a 0.23% change compared to the prior day closing price) with a volume of 817.34K shares and market capitalization of 4.18B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 595 people. Lantheus Holdings Inc. CEO is Mary Anne Heino.

The one-year performance of Lantheus Holdings Inc. stock is 132.24%, while year-to-date (YTD) performance is 19.31%. LNTH stock has a five-year performance of 177.63%. Its 52-week range is between 25.485 and 87.47, which gives LNTH stock a 52-week price range ratio of 56.97%

Lantheus Holdings Inc. currently has a PE ratio of 32.80, a price-to-book (PB) ratio of 5.23, a price-to-sale (PS) ratio of 4.89, a price to cashflow ratio of 17.80, a PEG ratio of 2.32, a ROA of 11.80%, a ROC of 14.79% and a ROE of 20.18%. The company’s profit margin is 21.92%, its EBITDA margin is 27.00%, and its revenue ttm is $671.89 Million , which makes it $9.76 revenue per share.

Of the last four earnings reports from Lantheus Holdings Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.87 for the next earnings report. Lantheus Holdings Inc.’s next earnings report date is 23rd Feb 2023.

The consensus rating of Wall Street analysts for Lantheus Holdings Inc. is Strong Buy (1), with a target price of $100.4, which is +65.13% compared to the current price. The earnings rating for Lantheus Holdings Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Lantheus Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Lantheus Holdings Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.34, ATR14 : 1.85, CCI20 : 157.25, Chaikin Money Flow : 0.28, MACD : 1.69, Money Flow Index : 84.57, ROC : 9.85, RSI : 73.59, STOCH (14,3) : 98.51, STOCH RSI : 1.00, UO : 76.10, Williams %R : -1.49), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Lantheus Holdings Inc. in the last 12-months were: Andrea Sabens (Sold 7 041 shares of value $405 210 ), Brian A. Markison (Option Excercise at a value of $483 320), Brian A. Markison (Sold 43 505 shares of value $3 655 192 ), Carol Walker (Sold 18 129 shares of value $1 003 783 ), Daniel M. Niedzwiecki (Sold 9 142 shares of value $607 993 ), Etienne Montagut (Sold 23 265 shares of value $1 396 427 ), Julie H. McHugh (Sold 7 280 shares of value $509 913 ), Mary Anne Heino (Sold 45 930 shares of value $2 709 378 ), Paul Blanchfield (Sold 6 142 shares of value $312 710 ), Paul M. Blanchfield (Sold 20 786 shares of value $1 162 297 ), Robert J. Marshall (Sold 31 778 shares of value $2 054 859 ), Samuel R. Leno (Option Excercise at a value of $102 482)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. The company's portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.

CEO: Mary Anne Heino

Telephone: +1 978 671-8001

Address: 331 Treble Cove Road, North Billerica 01862, MA, US

Number of employees: 595

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

53%47%

Bearish Bullish

47%53%


News

Stocktwits